Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.
about
Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNSNanotechnology-based drug delivery systems for the treatment of Alzheimer's diseaseEnabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicinesNanoscale drug delivery systems and the blood-brain barrierCentral nervous system toxicity of metallic nanoparticlesFunctionalized carbon nanotubes for potential medicinal applicationsUptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier modelEnhancing anti-tumor efficacy of Doxorubicin by non-covalent conjugation to gold nanoparticles - in vitro studies on feline fibrosarcoma cell linesNon-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound.Unilateral Opening of Rat Blood-Brain Barrier Assisted by Diagnostic Ultrasound Targeted Microbubbles Destruction.Progress and problems in the application of focused ultrasound for blood-brain barrier disruption.Challenges for Molecular Neuroimaging with MRI.Drug transport to brain with targeted nanoparticles.Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies.Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.Nanoparticle technology for drug delivery across the blood-brain barrier.Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles.A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo.Enhanced tumor uptake, biodistribution and pharmacokinetics of etoposide loaded nanoparticles in Dalton's lymphoma tumor bearing miceThermal and pH Sensitive Multifunctional Polymer Nanoparticles for Cancer Imaging and TherapyNovel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment.Cationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment.Targeted therapy for brain tumours.Brain-targeting study of stearic acid-grafted chitosan micelle drug-delivery systemNovel advances in drug delivery to brain cancer.Nanoparticle delivery systems in cancer vaccines.Nanotechnology and site-targeted drug delivery.Biomaterials for the central nervous systemTargeted nanoparticle-based drug delivery and diagnosis.Blood-brain barrier transport of therapeutics via receptor-mediationNanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.Nanotechnology-based detection and targeted therapy in cancer: nano-bio paradigms and applicationsFactors affecting the clearance and biodistribution of polymeric nanoparticles.Novel technologies for antiangiogenic drug delivery in the brain.A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles.Uses of nanoparticles for central nervous system imaging and therapy.Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.Nanomaterial standards for efficacy and toxicity assessment.A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers.
P2860
Q21262019-5DB9FC85-4936-4D2A-A75D-49FBECBB184CQ26783306-E309F4ED-1BAF-4915-A0F9-635BDC887F82Q26850868-B95C511F-0C9E-4E05-BA04-A92BED70EF9DQ27026978-A699DACC-BB5E-411C-9A2D-80E7E433E006Q28084729-4955D49D-3FF1-4EE7-8421-AC7550DA3F99Q28392143-1533FE75-784C-4B11-B194-41E7823BD60FQ28481345-19D1C48B-CD32-4C43-AC62-38E10C533D00Q28546881-20158345-11BF-4264-A60D-173E60960BFAQ30370894-56DDE9C0-53EB-4CFE-B396-F0CAF8A5AD40Q30375627-A7055865-38F5-415B-81D7-D147CCFFE4FAQ30487878-E5BFA751-5828-4DF0-AF1D-CCC8B9101657Q33680025-70597538-147A-4DE3-850D-3CA4A8B3ABD9Q33985140-FA0404EC-02B2-4C73-A938-436D8FC7E916Q33994463-81E7333B-0576-4EA2-97AB-95BDFE7B4434Q33996836-AD89656E-F95E-4D93-AB48-47742A4CAF70Q34030709-B976ABBA-A1FC-4E13-80A9-10309248848DQ34540557-0467BEF1-A1A5-41BA-BC0A-FEBFD88E4C22Q34701454-26243CB3-DE16-413A-BB12-EB16389E8E44Q35037158-96A7C840-560C-4BAD-A1B0-F4FEB339BAE9Q35058402-A1609AF4-09BA-4EB6-928B-4FA8E5653967Q35202143-13F8E08E-990E-4C39-AE16-581653F56C2BQ35556934-6C3C4053-66D3-4426-9DD2-15A879E6B7C5Q35609201-25B51691-F626-44E8-8466-74E2039B6093Q35790376-5E3B46A6-B8F1-41AF-B186-3710B7D4CA7CQ36093926-C7416C92-38C0-43CE-8E60-3A7FD4FC7F7FQ36200166-61935FA7-9B02-456F-A96F-C6B49B393382Q36574571-A08E448A-D33F-4AB5-B64F-498D2E1EBCBCQ36687169-F496215A-27E6-44D7-B66D-8B84D4A64E7AQ36777653-361FD7A4-C442-41E1-8941-5B4B0033B3AEQ36799773-C1508445-7ED5-4E50-8954-289235F78631Q36874295-D576959C-7004-42AD-9603-4961E36CCA65Q36933043-29007322-E93F-420F-B460-5D9657516082Q37137356-378BAC5E-6601-4C39-A390-4722836AAC90Q37146591-79FD3E99-EBD7-4D32-96BF-56E471AACD61Q37186246-87472B47-909F-4244-AD19-E479B9D7E2B8Q37413195-E88B7974-024F-4687-8CC7-C1798F92E174Q37555829-175F3A26-2B3C-4EC0-9391-292FDADDE010Q37668424-C4819CF9-8A14-4A1F-88B9-824100A18554Q37668451-4143B396-DD18-4E7C-ACF5-A4A775379943Q37798553-4E496EFD-EB05-4BD7-BFC7-C3FEC17CCA8B
P2860
Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Significant transport of doxor ...... rbate 80-coated nanoparticles.
@ast
Significant transport of doxor ...... rbate 80-coated nanoparticles.
@en
type
label
Significant transport of doxor ...... rbate 80-coated nanoparticles.
@ast
Significant transport of doxor ...... rbate 80-coated nanoparticles.
@en
prefLabel
Significant transport of doxor ...... rbate 80-coated nanoparticles.
@ast
Significant transport of doxor ...... rbate 80-coated nanoparticles.
@en
P2093
P356
P1476
Significant transport of doxor ...... orbate 80-coated nanoparticles
@en
P2093
A E Gulyaev
A S Antropov
G Y Kivman
I N Skidan
P304
P356
10.1023/A:1018983904537
P577
1999-10-01T00:00:00Z